Publications by authors named "Daniel Compagno"

Claim this Profile
I
Inhibition of galectins in cancer: Biological challenges for their clinical application.
Diego José Laderach, Daniel Compagno

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyfunctional KLRG-1CD57 Senescent CD4 T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.
Maria C Ramello, Nicolás G Núñez, Jimena Tosello Boari, Sabrina N Bossio, Fernando P Canale, Daniel Compagno

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
Diego José Laderach, Daniel Compagno

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.
Carolina Tiraboschi, Lucas Gentilini, Carla Velazquez, Enrique Corapi, Felipe Martín Jaworski, Daniel Compagno

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials.
Daniel Compagno, Carolina Tiraboschi, José Daniel Garcia, Yorfer Rondón, Enrique Corapi

Biomolecules· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.
Enrique Corapi, Gustavo Carrizo, Daniel Compagno, Diego Laderach

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.
Marine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, Catherine Gaudin, Frédéric Commo, Daniel Compagno

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.
Felipe M Jaworski, Lucas D Gentilini, Geraldine Gueron, Roberto P Meiss, Emiliano G Ortiz, Daniel Compagno

Clin Cancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.
Lucas Daniel Gentilini, Felipe Martín Jaworski, Carolina Tiraboschi, Ignacio González Pérez, Monica Lidia Kotler, Daniel Compagno

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
María L Bacigalupo, Malena Manzi, María V Espelt, Lucas D Gentilini, Daniel Compagno

J Cell Physiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of galectins in tumor immunity: strategies and methods.
Juan P Cerliani, Tomas Dalotto-Moreno, Daniel Compagno, L Sebastián Dergan-Dylon, Diego J Laderach

Methods Mol Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.
Mariana Salatino, Diego O Croci, Diego J Laderach, Daniel Compagno, Lucas Gentilini

Methods Mol Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-8: a matricellular lectin with key roles in angiogenesis.
María F Troncoso, Fátima Ferragut, María L Bacigalupo, Víctor M Cárdenas Delgado, Lorena G Nugnes, Daniel Compagno

Glycobiology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Daniel Compagno, Lucas D Gentilini, Felipe M Jaworski, Ignacio González Pérez, Geraldine Contrufo

Glycobiology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors.
María T Elola, Fátima Ferragut, Víctor M Cárdenas Delgado, Lorena G Nugnes, Lucas Gentilini, Daniel Compagno

Histol Histopathol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.
Diego J Laderach, Lucas Gentilini, Felipe M Jaworski, Daniel Compagno

Prostate Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineating the "galectin signature" of the tumor microenvironment.
Daniel Compagno, Diego J Laderach, Lucas Gentilini, Felipe M Jaworski, Gabriel A Rabinovich

Oncoimmunology· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Diego J Laderach, Lucas D Gentilini, Laura Giribaldi, Victor Cardenas Delgado, Lorena Nugnes, Daniel Compagno

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSLP1: a new piece in the puzzle of tumor-associated Th2-type inflammation.
Diego J Laderach, Susana A Pesoa, Daniel Compagno, Gabriel A Rabinovich

Immunotherapy· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Anne Chauchereau, Nader Al Nakouzi, Catherine Gaudin, Sylvestre Le Moulec, Daniel Compagno

Exp Cell Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.
Víctor M Cárdenas Delgado, Lorena G Nugnes, Lucas L Colombo, María F Troncoso, Marisa M Fernández, Daniel Compagno

FASEB J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
Diego J Laderach, Daniel Compagno, Marta A Toscano, Diego O Croci, Sebastián Dergan-Dylon

IUBMB Life· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dok-4 is a novel negative regulator of T cell activation.
Audrey Gérard, Marguerite Ghiotto, Camille Fos, Geoffrey Guittard, Daniel Compagno

J Immunol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.
Daniel Compagno, Carole Merle, Aurélie Morin, Cristèle Gilbert, Jacques R R Mathieu

PLoS One· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
Aurelie Olivier, Laurence Jeanson-Leh, Gerben Bouma, Daniel Compagno, Johanna Blondeau

Mol Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis